BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32128089)

  • 1. Thalidomide attenuates the hyporesponsiveness of isolated atria to chronotropic stimulation in BDL rats: The involvement of TNF-α, IL-6 inhibition, and SOCS1 activation.
    Hosseini-Chegeni A; Jazaeri F; Yousefi-Ahmadipour A; Heidari M; Abdollahie A; Dehpour AR
    Iran J Basic Med Sci; 2019 Nov; 22(11):1259-1266. PubMed ID: 32128089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats.
    Niaz Q; Tavangar SM; Mehreen S; Ghazi-Khansari M; Jazaeri F
    Life Sci; 2022 Nov; 308():120966. PubMed ID: 36150464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
    Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
    Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats.
    Jazaeri F; Afsharmoghaddam R; Abdollahi A; Ghamami G; Dehpour AR
    Acta Med Iran; 2018 Jan; 56(1):4-13. PubMed ID: 29436789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
    Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide decreases intrahepatic resistance in cirrhotic rats.
    Yang YY; Huang YT; Lin HC; Lee FY; Lee KC; Chau GY; Loong CC; Lai CR; Lee SD
    Biochem Biophys Res Commun; 2009 Mar; 380(3):666-72. PubMed ID: 19285019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats.
    Sheibani M; Nezamoleslami S; Mousavi SE; Faghir-Ghanesefat H; Yousefi-Manesh H; Rezayat SM; Dehpour A
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):286-295. PubMed ID: 32902943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic thalidomide administration enhances vascular responsiveness to vasopressin in portal-systemic collaterals of bile duct-ligated rats.
    Chang CC; Wang SS; Huang HC; Lee FY; Lin HC; Lee JY; Chen YC; Lee SD
    J Chin Med Assoc; 2009 May; 72(5):234-42. PubMed ID: 19467946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
    Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H
    PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endotoxin on heart rate dynamics in rats with cirrhosis.
    Haddadian Z; Eftekhari G; Mazloom R; Jazaeri F; Dehpour AR; Mani AR
    Auton Neurosci; 2013 Oct; 177(2):104-13. PubMed ID: 23511062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced imbalanced expression of hepatic vascular stress genes in cirrhosis: possible mechanism of increased susceptibility to endotoxemia.
    Baveja R; Keller S; Yokoyama Y; Sonin N; Clemens MG; Zhang JX
    Shock; 2002 Apr; 17(4):316-21. PubMed ID: 11954834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
    Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T
    Adv Med Sci; 2022 Mar; 67(1):154-162. PubMed ID: 35272246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
    Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
    Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats.
    Esmaeili Z; Niaz Q; Saffari PM; Dehpour AR; Rezayat SM; Jazaeri F
    Life Sci; 2021 May; 273():119261. PubMed ID: 33652036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.
    Mookerjee RP; Mehta G; Balasubramaniyan V; Mohamed Fel Z; Davies N; Sharma V; Iwakiri Y; Jalan R
    J Hepatol; 2015 Feb; 62(2):325-31. PubMed ID: 25152204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats.
    Hsin IF; Wang SS; Huang HC; Lee FY; Chan CY; Chang CC; Hsu CY; Lin HC; Lee SD
    J Chin Med Assoc; 2012 Jan; 75(1):3-9. PubMed ID: 22240529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas Receptor Activation by Endogenous Opioids Is A New Mechanism for Cardiomyopathy in Cirrhotic Rats.
    Abbasi A; Faramarzi N; Khosravi M; Yazarloo F; Abbasi MA; Dehpour AR; Jahanzad I
    J Clin Exp Hepatol; 2017 Jun; 7(2):107-114. PubMed ID: 28663674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.